A lawsuit was filed for investors in shares of RPX Corporation (NASDAQ: RPXC) in connection with the proposed takeover and NASDAQ: RPXC stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 06/11/2018 -- The Shareholders Foundation announces that an investor, who currently holds shares of RPX Corporation (NASDAQ: RPXC), filed a lawsuit in effort to halt the proposed takeover of RPX Corporation.
Investors who purchased shares of RPX Corporation (NASDAQ: RPXC) and currently hold any of those NASDAQ: RPXC shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors of RPX Corporation breached their fiduciary duties owed to NASDAQ: RPXC investors in connection with the proposed acquisition.
San Francisco, CA based RPX Corporation provides patent risk management and discovery services in the United States, Japan, South Korea, and internationally. On May 21, 2018, RPX Corporation (NASDAQ: RPXC) and HGGC, LLC announced that HGGC's affiliate, Riptide Purchaser, Inc., has commenced the previously announced tender offer for all outstanding shares of RPX's common stock at a purchase price of $10.50 per share, net to the seller in cash, subject to reduction for any applicable withholding taxes in respect thereof, without interest.
However, the plaintiff claims that the proposed consideration NASDAQ:RPXC shareholders will receive is grossly inadequate and undervalues RPX Corporation. Indeed, at least one analyst has set the high target price for NASDAQ:RPXC shares at $16.00 per share. In addition, the plaintiff alleges that the process is also unfair NASDAQ: RPXC stockholders.
Those who are current investors in RPX Corporation (NASDAQ: RPXC) shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels